Office of National Drug Control Policy and The National Institute on Drug…
In early October, the Office of National Drug Control Policy (ONDCP) and the National Institute on Drug Abuse (NIDA) launched a…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Foreign Corrupt Practices Act: Interview with Former Prosecutor
Over the past few years, the focus on the life sciences industry has increased dramatically, including cases under not only the…
CMS Final Rule Inpatient Prospective Payment System, Raises Hospital…
General acute care hospitals will see Medicare payment rates rise 2.3 percent in fiscal year 2013, after allowing for other…
FDA to Consider Accelerated Approval for Special Medical Use
Over the past few months, the Food and Drug Administration has approved a number of new drugs, including products for obesity and…
FDA to Study Disease Awareness Programs
The Food and Drug Administration (FDA) recently announced that it intends to study whether providing disease awareness information…
International: Supervised Off Label Marketing in France
Over the past several years, we have written numerous times about legal settlements involving pharmaceutical companies who were…
Pharmaceutical Development Slows Down In Search of New Products
Over the last month or so, there has been a series of reports and articles discussing the difficulty pharmaceutical companies are…
Cleveland Clinic CEO Expresses Concern for Affordable Care Act Effect on…
Cleveland Clinic Chief Executive Toby Cosgrove, recently expressed his reservations about some aspects of the federal Affordable…
Physician Payment Sunshine Act: CBI Chart – Shining Light on the…
As we continue to wait for the final regulations from the Centers for Medicare & Medicaid Services (CMS) to implement the…
CMS Opens Anti-Fraud Command Center – Senators Question FPS Effectiveness
The Centers for Medicare & Medicaid Services (CMS) recently announced the Program Integrity Commend Center in Baltimore to…